Source: International Congress 2016 – Monitoring comorbidities
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Aurelio V. Arnedillo Muñoz (Cádiz, Spain), Aurelio V. Arnedillo Muñoz, Jose Luis Lopez-Campos, Inmaculada Alfageme Michavilla, Francisco Casas Maldonado, Pilar Cordero Montero. Role of comorbidities in stable COPD patients mortality. Eur Respir J 2016; 48: Suppl. 60, 4146

Member's Comments

No comment yet.

Related content which might interest you: The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016